Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Deferred Taxes (2012 - 2026)

Iqvia Holdings' (IQV) quarterly Deferred Taxes came in at -$36.0 million in Q2 2026, up 20.0% year-over-year from -$30.0 million in Q2 2025, and up 5.26% quarter-over-quarter from -$38.0 million in Q1 2026.

Analysis

Iqvia Holdings (IQV) Deferred Taxes (2012 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Deferred Taxes across 15 years of filings, most recently posting -$36.0 million for Q2 2026.

  • In Q2 2026, Deferred Taxes rose 20.0% year-over-year to -$36.0 million; the TTM figure through Jun 2026 stood at -$168.0 million (down 24.44% YoY), while the FY2025 annual figure was -$180.0 million, down 39.53% from the prior year.
  • Deferred Taxes came in at -$36.0 million for Q2 2026 at Iqvia Holdings, up from -$38.0 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of -$10.0 million in Q1 2022 to a low of -$152.0 million in Q4 2023.
  • Average Deferred Taxes over 5 years is -$42.6 million, with a median of -$39.5 million recorded in 2025.
  • Year-over-year, Deferred Taxes sank 350.0% in 2022 and jumped 90.13% in 2024.
  • Over 5 years, Deferred Taxes stood at -$63.0 million in 2022, then tumbled by 141.27% to -$152.0 million in 2023, then jumped by 90.13% to -$15.0 million in 2024, then plunged by 220.0% to -$48.0 million in 2025, then gained by 25.0% to -$36.0 million in 2026.
  • Per Business Quant data, the three most recent Deferred Taxes figures were -$36.0 million in Q2 2026, -$38.0 million in Q1 2026, and -$48.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -36.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 4.28 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -3.28 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 41.49 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 4.90 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -36.00 Mn
Mar 31, 2026 -38.00 Mn
Dec 31, 2025 -48.00 Mn
Sep 30, 2025 -46.00 Mn
Jun 30, 2025 -45.00 Mn
Mar 31, 2025 -41.00 Mn
Dec 31, 2024 -15.00 Mn
Sep 30, 2024 -34.00 Mn
Jun 30, 2024 -14.00 Mn
Mar 31, 2024 -66.00 Mn
Dec 31, 2023 -152.00 Mn
Sep 30, 2023 -47.00 Mn
Jun 30, 2023 -43.00 Mn
Mar 31, 2023 -27.00 Mn
Dec 31, 2022 -63.00 Mn
Sep 30, 2022 -24.00 Mn
Jun 30, 2022 -18.00 Mn
Mar 31, 2022 -10.00 Mn
Dec 31, 2021 -55.00 Mn
Sep 30, 2021 -40.00 Mn